MDxHealth SA (MDXH)
(Delayed Data from NSDQ)
$2.73 USD
-0.08 (-2.85%)
Updated Jun 17, 2024 03:59 PM ET
After-Market: $2.73 0.00 (0.00%) 5:02 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Cash flow Statements
Fiscal Year End for MDxHealth SA falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -27.33 | -37.90 | -26.84 | -27.12 | -43.17 |
Depreciation/Amortization & Depletion | 6.86 | 4.91 | 3.04 | 3.33 | 3.42 |
Net Change from Assets/Liabilities | -2.12 | -1.57 | 0.36 | 1.98 | 10.30 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1.09 | 0.44 | 0.90 | 1.57 | 7.16 |
Net Cash From Operating Activities | -21.50 | -34.12 | -22.55 | -20.24 | -22.29 |
Property & Equipment | -2.75 | -2.79 | -0.90 | -0.54 | -0.07 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -25.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -1.18 | -1.37 | 0.01 | 0.00 | 0.00 |
Net Cash from Investing Activities | -3.93 | -29.16 | -0.89 | -0.54 | -0.07 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 39.60 | 0.00 | 68.57 | 13.88 | 9.58 |
Issuance (Repayment) of Debt | -1.66 | 23.49 | 0.00 | 2.32 | 9.52 |
Increase (Decrease) Short-Term Debt | -1.61 | -1.36 | -1.06 | -0.83 | -0.82 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -4.05 | -1.29 | -1.01 | -1.07 | -0.32 |
Net Cash from Financing Activities | 32.28 | 20.84 | 66.50 | 14.29 | 17.97 |
Effect of Exchange Rate Changes | 0.03 | -0.56 | -0.52 | 0.39 | 0.24 |
Net Change In Cash & Equivalents | 6.88 | -43.00 | 42.55 | -6.10 | -4.15 |
Cash at Beginning of Period | 15.50 | 58.50 | 15.95 | 22.05 | 26.20 |
Cash at End of Period | 22.38 | 15.50 | 58.50 | 15.95 | 22.05 |
Diluted Net EPS | -1.66 | -2.80 | -2.40 | -3.40 | -6.90 |
Fiscal Year End for MDxHealth SA falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -6.60 | -27.33 | -21.02 | -16.46 | -8.72 |
Depreciation/Amortization & Depletion | 1.90 | 6.86 | 5.28 | 3.41 | 1.64 |
Net Change from Assets/Liabilities | -0.98 | -2.12 | 0.89 | 2.91 | 1.84 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | NA | 0.00 |
Other Operating Activities | 0.17 | 1.09 | 0.73 | 0.28 | 0.97 |
Net Cash From Operating Activities | -5.52 | -21.50 | -14.12 | -9.86 | -4.27 |
Property & Equipment | -0.22 | -2.75 | -2.40 | -2.15 | -0.79 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | NA | 0.00 |
Investments | NA | 0.00 | 0.00 | NA | 0.00 |
Other Investing Activities | -0.40 | -1.18 | -0.86 | -0.66 | -0.46 |
Net Cash from Investing Activities | -0.62 | -3.93 | -3.26 | -2.82 | -1.24 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 39.60 | 39.60 | 39.60 | 39.60 |
Issuance (Repayment) of Debt | -0.16 | -1.66 | -0.99 | -0.32 | -0.16 |
Increase (Decrease) Short-Term Debt | -0.48 | -1.61 | -1.12 | -0.71 | -0.35 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | NA | 0.00 |
Other Financing Activities | -1.12 | -4.05 | -2.92 | -1.73 | -0.83 |
Net Cash from Financing Activities | -1.75 | 32.28 | 34.57 | 36.84 | 38.27 |
Effect of Exchange Rate Changes | 0.00 | 0.03 | 0.02 | -0.19 | -0.01 |
Net Change In Cash & Equivalents | -7.89 | 6.88 | 17.21 | 23.97 | 32.75 |
Cash at Beginning of Period | 22.38 | 15.50 | 15.50 | 15.50 | 15.50 |
Cash at End of Period | 14.49 | 22.38 | 32.71 | 39.47 | 48.25 |
Diluted Net EPS | -0.31 | -0.39 | -0.40 | NA | -0.50 |